询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
1,4-Diiodooctafluorobutane | CAS:375-50-8
1,4-Diiodooctafluorobutane
  • 名称:1,4-二碘八氟丁烷 | 1,4-Diiodooctafluorobutane
  • CAS号:375-50-8
  • 别名:Octafluoro-1,4-diiodobutane
  • 分子式:C4F8I2
  • 分子量:453.84
  • EINESC号:206-788-4

产品描述

物理化学性质

熔点 -9 ºC
沸点 150 ºC
密度 2.474
折射率 1.429

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Wide distribution of the MICA-MICB null haplotype in East Asians.M Komatsu-Wakui et al.Tissue antigens, 57(1), 1-8 (2001-02-13) Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.Federica Sicca et al.Vaccine, 38(11), 2527-2541 (2020-02-12) A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.Alexander I Makarkov et al.Vaccine, 36(30), 4485-4493 (2018-06-23) Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.Felix Broecker et al.Journal of virology, 92(20) (2018-07-27) Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.G F Gao et al.The Journal of biological chemistry, 275(20), 15232-15238 (2000-05-16) Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.Avishekh Gautam et al.Frontiers in immunology, 10, 1160-1160 (2019-06-14) Characterization of a novel synGAP isoform, synGAP-beta.W Li et al.The Journal of biological chemistry, 276(24), 21417-21424 (2001-03-30) MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype.M Komatsu-Wakui et al.Immunogenetics, 49(7-8), 620-628 (1999-06-17) Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo.M E Ellexson-Turner et al.Human immunology, 62(6), 639-644 (2001-06-08) Distribution of MICA diversity in the Chinese Han population by polymerase chain reaction sequence-based typing for exons 2-6.F Zhu et al.Tissue antigens, 73(4), 358-363 (2009-03-26) Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.Narges Gholizadeh et al.Molecular biology reports, 47(2), 1223-1232 (2019-12-13) Evolutionary relationships between HLA-B alleles as indicated by an analysis of intron sequences.E Gomez-Casado et al.Tissue antigens, 53(2), 153-160 (1999-03-25) High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population.J E García-Ortiz et al.Tissue antigens, 68(2), 135-146 (2006-07-27) Human leukocyte antigen profile in HIV-1 infected individuals and AIDS patients from Chongqing, China.Xia Huang et al.Microbiology and immunology, 53(9), 512-523 (2009-08-26) HLA-A, HLA-B and HLA-C polymorphism in the Slovak population.E Kulcsárová et al.Folia biologica, 46(4), 153-156 (2000-08-23) HLA genes in Uros from Titikaka Lake, Peru: origin and relationship with other Amerindians and worldwide populations.A Arnaiz-Villena et al.International journal of immunogenetics, 36(3), 159-167 (2009-06-06) HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.S Yashiki et al.AIDS research and human retroviruses, 17(11), 1047-1061 (2001-08-04) Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).Tetsuo Kase et al.Vaccine, 38(42), 6524-6532 (2020-09-03) Novel HLA-B35 subtypes: putative gene conversion events with donor sequences from alleles common in native Americans (HLA-B*4002 or B*4801).C Y Marcos et al.Human immunology, 53(2), 148-155 (1997-04-01) Interactions of HLA-B*4801 with peptide and CD8.E Martinez-Naves et al.Tissue antigens, 50(3), 258-264 (1997-10-23)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交